Monday, January 26, 2026
No menu items!
HomeNatureWhy cancer might protect against Alzheimer’s disease

Why cancer might protect against Alzheimer’s disease

You have full access to this article via your institution.

Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here.

Coloured outline of a man exhaling warm breath on a black background with his head in silhouette.

Exhaled breath can have hundreds of different compounds in it, some of which could have diagnostic potential.Credit: Getty

The chemicals found in a person’s breath might reveal the identity of the microbes in their gut. Researchers measured the levels of bacterial metabolites in the exhaled breath of mice and children and showed that they could be used to partially predict the identity and abundance of certain gut bacteria, including one species that is associated with asthma. The findings could lead to devices that help to guide treatment of conditions influenced by gut bacteria more quickly than existing methods that test stool samples.

Nature | 4 min read

Reference: Cell Metabolism paper

Cystatin C, a protein produced by cancer cells, could partially explain why people who have had cancer have a lower risk of Alzheimer’s disease. In a study in mice, researchers found that the protein can infiltrate the brain and bind to the molecules that make up the hallmark brain plaques of Alzheimer’s disease. This interaction draws the attention of immune cells, which then degrade the plaques. If confirmed in humans, the findings could suggest a path toward new therapies for Alzheimer’s, says cancer researcher Jeanne Mandelblatt.

Nature | 5 min read

Reference: Cell paper

US-funded hepatitis B vaccine trial in Guinea-Bissau

News

Confusion is swirling around a US-funded hepatitis B vaccine trial, which critics say will cause harm and is designed to undermine trust in the jab. Officials from Guinea-Bissau’s health ministry say that the trial is suspended. But the US Department of Health and Human Services (HHS) told Nature that the study was still on track. The vaccine is among those that US health officials, under HHS leader and anti-vaccine activist Robert F. Kennedy Jr, recently stopped recommending for newborns in the United States. “They’re trying to use African children to prove a case for reducing vaccines in the US,” says Seye Abimbola, who researches decolonizing global health.

Nature | 5 min read

Opinion

Some scientists have argued the randomized nature of the trial puts babies at risk. Some will not receive an intervention that is known to be safe and life-saving (the World Health Organization recommends a first dose within 24 hours after birth) in a location where the risk of hepatitis B infection is high. Paediatrician Paul Offit, who pioneered a rotavirus vaccine, likened the trial to the infamous Tuskegee syphilis study that misled Black participants and left them without treatment for decades.

Beyond the Noise personal blog | 6 min read

Feature

Critics have questioned the HHS’s choice of scientists to run the trial: anthropologist Peter Aaby and vaccinologist Christine Stabell Benn of the Bandim Health Project. Their research is popular with Robert F. Kennedy Jr and others who cast doubt on the evidence for the safety of vaccines, and it has come under scrutiny for its rigour.

Rolling Stone | 16 min read

Features & opinion

For decades, stimulants such as Ritalin and Adderall have been enormously useful for some people seeking treatment for their attention deficit hyperactivity disorder (ADHD). But the drugs aren’t suited to everybody — and numerous alternatives are now emerging. These include medications that work in a similar way to stimulants without being addictive, and those that change how different parts of the brain communicate. And non-pharmacological treatments — such as attention-training video games, and electrical or magnetic brain stimulation — offer tentative promise. “Our dream would be: I see the patient, I do a scan, I do a genetic test,” says Samuele Cortese, a child psychiatrist and ADHD researcher. “Given your characteristics, this is the medication, the treatment for you. We are very, very far from this.”

Nature | 8 min read

This article is part of Nature Outlook: ADHD, an editorially independent supplement produced with financial support from Otsuka America Pharmaceutical, Inc.

A parent explains their absence from their child’s life in The rich stopped buying yachts the year time went on sale.

Nature | 6 min read

Andrew Robinson’s pick of the top five science books to read this week includes an illustrated biography of Antoni van Leeuwenhoek — ‘the father of microbiology’ — and a guide to the multiverse theory for non-mathematicians.

Nature | 3 min read

Using a painstakingly constructed experimental set-up, researchers have managed to put clusters of around 7,000 sodium atoms into the state of ‘superposition’, in which they exist in a haze of possible locations spaced 133 nanometres apart. It’s the biggest example yet of pushing ever-larger objects into quantum states to probe the boundary between the quantum and classical worlds, explains physicist Sebastian Pedalino. “I think at the most fundamental level, the motivation for our experiments is, ‘does quantum physics that explains the physics of light and atoms also hold for larger and more complex objects, or does something new make the world look classical as things get bigger?’”

Nature Podcast | 28 min listen

Subscribe to the Nature Podcast on Apple Podcasts, Spotify or YouTube Music, or use the RSS feed.

Quote of the day

Professions of love are among the messages and drawings scratched into a passageway in Pompeii — graffiti that has been further illuminated by a project to use the latest technology to ensure no ribald joke or scatological snippet is missed. It newly identified 79 inscriptions, on top of around 200 already known, in an alley that connected the theatre district of the doomed Roman town with a thoroughfare. (Reuters | 5 min read)

Reference: e-Journal degli Scavi di Pompei report

In today’s penguin puzzle, Leif Penguinson is hiding somewhere among the lovely llamas in Bolivia’s Sajama National Park, home to the stunning chullpas (burial towers) left by the ancient Aymara people. Can you find the penguin?

The answer will be in Monday’s e-mail, all thanks to Briefing photo editor and penguin wrangler Tom Houghton.

This newsletter is always evolving — tell us what you think! Please send your feedback to [email protected].

Thanks for reading,

Flora Graham, senior editor, Nature Briefing

With contributions by Jacob Smith

Nature Briefing: Careers — insights, advice and award-winning journalism to help you optimize your working life

Nature Briefing: Microbiology — the most abundant living entities on our planet — microorganisms — and the role they play in health, the environment and food systems

Nature Briefing: Anthropocene — climate change, biodiversity, sustainability and geoengineering

Nature Briefing: AI & Robotics — 100% written by humans, of course

Nature Briefing: Cancer — a weekly newsletter written with cancer researchers in mind

Nature Briefing: Translational Research — covers biotechnology, drug discovery and pharma

RELATED ARTICLES

Most Popular

Recent Comments